This is exemplified by constitutional BRCA1 promoter methylation, and numerous studies have demonstrated that this epimutation is substantially associated with early-onset triple-negative breast cancer (TNBC) subtypes and high-grade serous ovarian cancer (HGSOC) [3,4,5,6]. The gene discussed is BRCA1; the disease is triple-negative breast carcinoma.